FIGURE 1.

A and B, Prognosis analysis of all children with acute monocytic leukemia (AML)‐M5 according to the presence of molecular alterations: Prognostic analysis of 132 AML‐M5 children was performed using four of the most common fusion genes. Children with CBF‐AML (AML1/ETO or CBFβ/MYH11) had the best prognosis regarding overall survival (OS) and progression‐free survival (PFS). Notably, children with NRAS had intermediate outcomes concerning OS and PFS, whereas patients with MLL‐R, FLT3‐ITD had the poorer OS and PFS